- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
AI & Medical Imaging: The Ethical Issues, Pt. 1
What’s critical, and what radiologists can do.
The use of artificial intelligence (AI) in medical imaging is not new – in fact, it has been a topic of conversation at the Radiological Society of North America (RSNA) annual meeting for at least the past five years. And, with that continued growth comes the obligation among radiologists to approach its use in medical imaging in the most ethical ways possible.
On Monday, radiology ethics expert David Larson, M.D., professor radiology at Stanford University, discussed how data used in AI tools are now being applied to clinical care. That information holds tremendous value, but the industry does not yet have the ethical, regulatory, and legal constructs in place to ensure the data is handled in the most proper fashion.
To delve into the ethical issues that are facing radiology currently, as well as what radiologists can do ensure they approach this situations and opportunities appropriately, Diagnostic Imaging spoke with Larson about what he discussed.
For more RSNA coverage, click here.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
Mammography-Based AI Abnormality Scoring May Improve Prediction of Invasive Upgrade of DCIS
April 9th 2024Emerging research suggests that an artificial intelligence (AI) score of 75 or greater for mammography abnormalities more than doubles the likelihood of invasive upgrade of ductal carcinoma in situ (DCIS) diagnosed with percutaneous biopsy.
